|
🐜
|
Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases
7 auth.
P. Stolt,
C. Bengtsson,
B. Nordmark,
S. Lindblad,
I. Lundberg,
Lars Klareskog,
...
L. Alfredsson
|
9 |
2003 |
9
🐜
|
|
🐜
|
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
17 auth.
J. Askling,
C. M. Fored,
E. Baecklund,
L. Brandt,
C. Backlin,
A. Ekbom,
C. Sundström,
L. Bertilsson,
L. Cöster,
P. Geborek,
...
L. Jacobsson,
S. Lindblad,
J. Lysholm,
S. Rantapää-Dahlqvist,
T. Saxne,
Lars Klareskog,
N. Feltelius
|
8 |
2005 |
8
🐜
|
|
🐜
|
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.
15 auth.
J. Askling,
C. M. Fored,
L. Brandt,
E. Baecklund,
L. Bertilsson,
L. Cöster,
P. Geborek,
L. Jacobsson,
S. Lindblad,
J. Lysholm,
...
S. Rantapää-Dahlqvist,
T. Saxne,
V. Romanus,
L. Klareskog,
N. Feltelius
|
8 |
2005 |
8
🐜
|
|
🐜
|
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
14 auth.
J. Askling,
C. M. Fored,
L. Brandt,
E. Baecklund,
L. Bertilsson,
N. Feltelius,
L. Cöster,
P. Geborek,
L. Jacobsson,
S. Lindblad,
...
J. Lysholm,
S. Rantapää-Dahlqvist,
T. Saxne,
Lars Klareskog
|
8 |
2005 |
8
🐜
|
|
🐜
|
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression
7 auth.
J. Rönnelid,
M. Wick,
J. Lampa,
S. Lindblad,
B. Nordmark,
Lars Klareskog,
...
R. Vollenhoven
|
8 |
2005 |
8
🐜
|
|
🐜
|
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
15 auth.
J. Askling,
C. M. Fored,
L. Brandt,
E. Baecklund,
L. Bertilsson,
N. Feltelius,
L. Cöster,
P. Geborek,
L. Jacobsson,
S. Lindblad,
...
J. Lysholm,
S. Rantapää-Dahlqvist,
T. Saxne,
R. V. van Vollenhoven,
L. Klareskog
|
8 |
2007 |
8
🐜
|
|
🐜
|
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
16 auth.
J. Askling,
E. Baecklund,
Fredrik Granath,
P. Geborek,
M. Fored,
C. Backlin,
L. Bertilsson,
L. Cöster,
L. Jacobsson,
S. Lindblad,
...
J. Lysholm,
S. Rantapää-Dahlqvist,
T. Saxne,
R. Vollenhoven,
Lars Klareskog,
N. Feltelius
|
8 |
2008 |
8
🐜
|
|
🐜
|
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
15 auth.
J. Askling,
R. V. van Vollenhoven,
F. Granath,
P. Raaschou,
C. M. Fored,
E. Baecklund,
C. Dackhammar,
N. Feltelius,
L. Cöster,
P. Geborek,
...
L. Jacobsson,
S. Lindblad,
S. Rantapää-Dahlqvist,
T. Saxne,
L. Klareskog
|
8 |
2009 |
8
🐜
|
|
🐜
|
Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts.
9 auth.
S. Saevarsdottir,
S. Wedrén,
M. Seddighzadeh,
C. Bengtsson,
A. Wesley,
S. Lindblad,
...
J. Askling,
L. Alfredsson,
L. Klareskog
|
7 |
2011 |
7
🐜
|
|
🐬
|
Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.
A. Ulfgren,
S. Lindblad,
Lars Klareskog,
J. Andersson,
U. Andersson
|
7 |
1995 |
7
🐬
|
|
🦁
|
Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis.
S. Lindblad,
E. Hedfors
|
7 |
1987 |
7
🦁
|
